Quantum Biopharma (QNTM) Share-based Compensation (IS) (2019 - 2026)

Quantum Biopharma has disclosed Share-based Compensation (IS) across 8 years of filings, most recently posting $892057.0 for Q1 2026.

• Share-based Compensation (IS) for Q1 2026 came in at $892057.0, up 206.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 574.25% YoY), and the FY2025 annual result was $2.9 million, up 1835.11% from the prior year.
• Share-based Compensation (IS) came in at $892057.0 for Q1 2026 at Quantum Biopharma, up from $808452.0 in the prior quarter.
• In the past five years, Share-based Compensation (IS) ranged from a high of $3.2 million in Q1 2023 to a low of $57743.0 in Q1 2024.
• The 5-year median for Share-based Compensation (IS) is $208717.5 (2023), against an average of $628821.0.
• Across the five-year window, Share-based Compensation (IS) soared 3755.82% in 2023 and plunged 98.2% in 2024, its largest moves.
• Quantum Biopharma's Share-based Compensation (IS) stood at $83161.0 in 2022, then soared by 51.71% to $126163.0 in 2023, then tumbled by 54.23% to $57743.0 in 2024, then surged by 1300.09% to $808452.0 in 2025, then gained by 10.34% to $892057.0 in 2026.
• The last three Share-based Compensation (IS) figures came in at $892057.0 (Q1 2026), $808452.0 (Q4 2025), and $996194.0 (Q3 2025), per Business Quant data.